Patents by Inventor Paul Michael Scola

Paul Michael Scola has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hepatitis C virus inhibitors
    Patent number: 8044023
    Abstract: Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Grant
    Filed: May 28, 2009
    Date of Patent: October 25, 2011
    Assignee: Bristol-Myers Squibb Company
    Inventors: Alan Xiangdong Wang, Paul Michael Scola
  • Hepatitis C virus inhibitors
    Patent number: 8044087
    Abstract: Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Grant
    Filed: September 24, 2009
    Date of Patent: October 25, 2011
    Assignee: Bristol-Myers Squibb Company
    Inventors: Alan Xiangdong Wang, Ramkumar Rajamani, Paul Michael Scola
  • Hepatitis C virus inhibitors
    Patent number: 8003604
    Abstract: Macrocyclic peptides having the general formula: are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Grant
    Filed: November 14, 2007
    Date of Patent: August 23, 2011
    Assignee: Bristol-Myers Squibb Company
    Inventors: Alan Xiangdong Wang, Barbara Zhizhen Zheng, Stanley D'Andrea, Nicholas A. Meanwell, Paul Michael Scola
  • Hepatitis C virus inhibitors
    Patent number: 7964560
    Abstract: Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Grant
    Filed: May 27, 2009
    Date of Patent: June 21, 2011
    Assignee: Bristol-Myers Squibb Company
    Inventors: Alan Xiangdong Wang, Paul Michael Scola
  • Hepatitis C virus inhibitors
    Patent number: 7935670
    Abstract: Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Grant
    Filed: July 10, 2007
    Date of Patent: May 3, 2011
    Assignee: Bristol-Myers Squibb Company
    Inventors: Paul Michael Scola, Li-Qiang Sun
  • Compounds for the Treatment of Hepatitis C
    Publication number: 20110086858
    Abstract: The disclosure provides compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
    Type: Application
    Filed: October 14, 2010
    Publication date: April 14, 2011
    Inventors: Tao Wang, Annapurna Pendri, Zhongxing Zhang, Weixu Zhai, Guo Li, Samuel Gerritz, Paul Michael Scola, Li-Qiang Sun, Qian Zhao, Eric Mull
  • Hepatitis C virus inhibitors
    Patent number: 7915291
    Abstract: Hepatitis C virus inhibitors are disclosed having the general formula: wherein R1, R2, R3, R?, B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Grant
    Filed: September 2, 2008
    Date of Patent: March 29, 2011
    Assignee: Bristol-Myers Squibb Company
    Inventors: Xiangdong Alan Wang, Li-Qiang Sun, Sing-Yuen Sit, Ny Sin, Paul Michael Scola, Yan Chen
  • Hepatitis C virus inhibitors
    Patent number: 7888464
    Abstract: Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Grant
    Filed: November 14, 2007
    Date of Patent: February 15, 2011
    Assignee: Bristol-Myers Squibb Company
    Inventors: Alan Xiangdong Wang, Barbara Zhizhen Zheng, Stanley D'Andrea, Qian Zhao, Paul Michael Scola
  • Hepatitis C Virus Inhibitors
    Publication number: 20100272674
    Abstract: Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: December 1, 2009
    Publication date: October 28, 2010
    Inventors: Sheldon Hiebert, Paul Michael Scola
  • Hepatitis C virus inhibitors
    Patent number: 7772183
    Abstract: Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Grant
    Filed: October 11, 2006
    Date of Patent: August 10, 2010
    Assignee: Bristol-Myers Squibb Company
    Inventors: David J. Carini, Barry L. Johnson, Zhizhen Barbara Zheng, Stanley D'Andrea, Paul Michael Scola
  • Hepatitis C virus inhibitors
    Patent number: 7772180
    Abstract: Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Grant
    Filed: November 5, 2007
    Date of Patent: August 10, 2010
    Assignee: Bristol-Myers Squibb Company
    Inventors: Ny Sin, Brian Lee Venables, Li-Qiang Sun, Sing-Yuen Sit, Yan Chen, Paul Michael Scola
  • Hepatitis C virus inhibitors
    Patent number: 7763584
    Abstract: Macrocyclic peptides having the general formula: are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Grant
    Filed: November 14, 2007
    Date of Patent: July 27, 2010
    Assignee: Bristol-Myers Squibb Company
    Inventors: Alan Xiangdong Wang, Barbara Zhizhen Zheng, Stanley D'Andrea, Nicholas A. Meanwell, Paul Michael Scola
  • Hepatitis C virus inhibitors
    Patent number: 7741281
    Abstract: Macrocyclic peptides are disclosed having the general formula: wherein R?, R3, R3?, R4, R6, X, Q, and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Grant
    Filed: November 1, 2006
    Date of Patent: June 22, 2010
    Assignee: Bristol-Myers Squibb Company
    Inventors: Stanley D'Andrea, Zhizhen Barbara Zheng, Jeffrey Allen Campbell, Fiona McPhee, Andrew Charles Good, Paul Michael Scola
  • Hepatitis C Virus Inhibitors
    Publication number: 20100150866
    Abstract: Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: December 10, 2009
    Publication date: June 17, 2010
    Inventors: Alan Xiangdong Wang, Paul Michael Scola
  • Hepatitis C Virus Inhibitors
    Publication number: 20100080771
    Abstract: Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: September 24, 2009
    Publication date: April 1, 2010
    Inventors: Sheldon Hiebert, Michael S. Bowsher, Ramkumar Rajamani, Rongti Li, Paul Michael Scola
  • Hepatitis C Virus Inhibitors
    Publication number: 20100080770
    Abstract: Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: September 14, 2009
    Publication date: April 1, 2010
    Inventors: Sheldon Hiebert, Ramkumar Rajamani, Michael S. Bowsher, Rongti Li, Paul Michael Scola
  • Hepatitis C Virus Inhibitors
    Publication number: 20100081700
    Abstract: Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: September 24, 2009
    Publication date: April 1, 2010
    Inventors: Alan Xiangdong Wang, Ramkumar Rajamani, Paul Michael Scola
  • Hepatitis C Virus Inhibitors
    Publication number: 20090304626
    Abstract: Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: May 27, 2009
    Publication date: December 10, 2009
    Inventors: Alan Xiangdong Wang, Paul Michael Scola
  • Hepatitis C Virus Inhibitors
    Publication number: 20090297472
    Abstract: Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: May 28, 2009
    Publication date: December 3, 2009
    Inventors: Alan Xiangdong Wang, Paul Michael Scola
  • Hepatitis C Virus Inhibitors
    Publication number: 20090285773
    Abstract: Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: May 13, 2009
    Publication date: November 19, 2009
    Inventors: Li-Qiang Sun, Paul Michael Scola